AYURDA: Ayurvedic Nutritional Counseling for Patients With IBS in Comparison to Conventional Nutritional Counseling
Study Details
Study Description
Brief Summary
The main goal of this randomized controlled clinical study is to evaluate the efficacy of an individual Ayurvedic nutritional counseling (according to tradition) compared to an individual conventional dietary advice (according to the German Nutrition Society - DGE) in patients with irritable bowel syndrome. It is to be investigated whether nutritional therapy elements, which patients can self-implement independently in the home environment, can achieve sustainable therapy effects.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Ayurvedic nutritional counseling Patients will receive three Ayurvedic nutritional counselings (according to tradition) after 1, 3 and 8 weeks after Baseline. |
Behavioral: Ayurvedic nutritional counseling
|
Active Comparator: Conventional nutritional counseling Patients will receive three conventional nutritional counselings (according to German Nutrition Society - DGE) after 1, 3 and 8 weeks after Baseline. |
Behavioral: Conventional nutritional counseling
|
Outcome Measures
Primary Outcome Measures
- Irritable Bowel Syndrome-Severity Scoring System (IBS-SSS) - Change [Change from IBS-SSS Baseline at 12 weeks]
Secondary Outcome Measures
- Cohen Perceived Stress Scale (CPSS) - Change [Change from CPSS Baseline at 4 weeks, 12 weeks and 6 months]
- Hospital Anxiety and Depression Scale (HADS-D) - Change [Change from HADS-D Baseline at 4 weeks, 12 weeks and 6 months]
- Irritable bowel Syndrome - Quality of life (IBS-QOL) - Change [Change from IBS-QOL Baseline at 4 weeks, 12 weeks and 6 months]
- VAS: Pain, Sleep, General bothersomeness, Expectation - Change [Change from VAS Baseline at 4 weeks, 12 weeks and 6 months]
- Irritable Bowel Syndrome-Severity Scoring System (IBS-SSS) - Change [Change from IBS-SSS Baseline at 4 weeks and 6 months]
Other Outcome Measures
- Stool analysis: Intestinal microbiome by sequencing 16S rRNA [Baseline, 4 weeks]
- Qualitative interviews in focus groups [Baseline, 6 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Diagnosis "irritable bowel syndrome" according to the ROM-III criteria and the German S3 guideline (Layer 2011)
-
Female and male patients between 18 and 70 years of age
-
Declaration of consent
Exclusion Criteria:
-
Bad general condition
-
Serious acute or chronic comorbidity
-
Pregnancy and breast feeding period
-
Eating disorder
-
In recognition procedures for early retirement or disability
-
Simultaneous participation in another clinical trial
-
Participation in a clinical trial within the last 3 months before enrollment
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Kliniken Essen-Mitte | Essen | Am Deimelsberg 34 A | Germany | 45276 |
2 | Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus | Berlin | Germany | 14109 |
Sponsors and Collaborators
- Charite University, Berlin, Germany
Investigators
- Principal Investigator: Andreas Michalsen, Prof. Dr., Charité University Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- AYURDA